Mesenchymal Stem Cells Modified with a Single-Chain Antibody against EGFRvIII Successfully Inhibit the Growth of Human Xenograft Malignant Glioma

Irina V. Balyasnikova, Sherise D. Ferguson, Sadhak Sengupta et al. · 2010

Read Mesenchymal Stem Cells Modified with a Single-Chain Antibody against EGFRvIII Successfully Inhibit the Growth of Human Xenograft Malignant Glioma by Irina V. Balyasnikova, Sherise D. Ferguson, Sadhak Sengupta et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0009750.txt.

Description

Irina V. Balyasnikova and co-authors published a brain tumor study in PLOS ONE in 2010. The study uses human stem cells from marrow, fitted with a small antibody that locks onto a tumor-only marker called EGFRvIII. The aim was a better therapy for glioblastoma, the most lethal brain tumor.

Fitted stem cells slowed tumor growth in dishes and clung to tumors in mice far more than plain stem cells. Flank tumors grew 50 percent less with the fitted cells. Mice with brain tumors lived longer when given the cells, and longer still with a second dose two weeks later.

Catalog record

CREATORIrina V. Balyasnikova, Sherise D. Ferguson, Sadhak Sengupta et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE53 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0009750

Browse the full library · About the Tower of Babel